Nephros Inc (NEPH)
Nephros, Inc. is a commercial-stage company focused on water filtration solutions for medical and commercial use in the United States. Its ultrafiltration products are used in dialysis centers to help remove biological contaminants from water and bicarbonate concentrate, and in hospitals to support infection prevention related to waterborne pathogens such as legionella and pseudomonas. The company also supplies water filters designed to improve taste and odor while reducing biofilm and scale buildup and removing cysts, particulates, and lead from water systems. Nephros serves foodservice and hospitality customers, including quick-service restaurants, convenience stores, and other restaurant operators. Incorporated in 1997, the company is headquartered in South Orange, New Jersey.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-NEPH
|
$3.57
|
-0.6% Downside
|
Fair
|
$6
|
66.9% Upside
|
Bargain
|
Good
|
—
|
—
|
—
|
0.0%
|
August 12, 2026
|
50.3x
|
3.6x
|
2.0x
|
39.952 M
|
35.979 M
|
2.4%
|
81.3%
|
-5.6
|
—
|
-44.8%
|
